Healthcare provider profile · identity verified

Stephen Perryman

Family Practice · PITTSBURGH, PA · NPI 1184699613

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	190
Amlodipine Besylate	Amlodipine Besylate	284	71
Levothyroxine Sodium	Levothyroxine Sodium	274	61
Lisinopril	Lisinopril	269	68
Losartan Potassium	Losartan Potassium	243	74
Gabapentin	Gabapentin	229	41
Omeprazole	Omeprazole	213	53
Rosuvastatin Calcium	Rosuvastatin Calcium	210	60
Hydrochlorothiazide	Hydrochlorothiazide	160	45
Famotidine	Famotidine	154	37
Sertraline Hcl	Sertraline Hcl	154	36
Pantoprazole Sodium	Pantoprazole Sodium	145	35
Furosemide	Furosemide	138	29
Fluticasone Propionate	Fluticasone Propionate	132	41
Metformin Hcl	Metformin Hcl	128	36
Albuterol Sulfate Hfa	Albuterol Sulfate	122	34
Eliquis	Apixaban	117	28
Tamsulosin Hcl	Tamsulosin Hcl	116	33
Carvedilol	Carvedilol	111	31
Duloxetine Hcl	Duloxetine Hcl	104	20
Ozempic	Semaglutide	100	15
Metoprolol Tartrate	Metoprolol Tartrate	97	29
Fluoxetine Hcl	Fluoxetine Hcl	76	21
Alendronate Sodium	Alendronate Sodium	73	18
Simvastatin	Simvastatin	73	14
Ezetimibe	Ezetimibe	70	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	16
Allopurinol	Allopurinol	64	17
Montelukast Sodium	Montelukast Sodium	64	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	13
Mounjaro	Tirzepatide	59	14
Buspirone Hcl	Buspirone Hcl	58	12
Metformin Hcl Er	Metformin Hcl	58	12
Azelastine Hcl	Azelastine Hcl	56	17
Finasteride	Finasteride	52	11
Synthroid	Levothyroxine Sodium	52	11
Atenolol	Atenolol	51	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	17
Bupropion Hcl Sr	Bupropion Hcl	50	12
Jardiance	Empagliflozin	50	17
Valsartan	Valsartan	48	12
Naproxen	Naproxen	47	suppressed
Trazodone Hcl	Trazodone Hcl	47	20
Glipizide	Glipizide	46	12
Meloxicam	Meloxicam	46	14
Citalopram Hbr	Citalopram Hydrobromide	45	11
Potassium Chloride	Potassium Chloride	45	11
Metoprolol Succinate	Metoprolol Succinate	44	16
Topiramate	Topiramate	42	suppressed
Alprazolam	Alprazolam	39	suppressed
Celecoxib	Celecoxib	39	suppressed
Ibuprofen	Ibuprofen	39	13
Lansoprazole	Lansoprazole	39	11
Warfarin Sodium	Warfarin Sodium	39	suppressed
Xarelto	Rivaroxaban	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	11
Valacyclovir	Valacyclovir Hcl	36	13
Donepezil Hcl	Donepezil Hcl	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Irbesartan	Irbesartan	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	18
Doxepin Hcl	Doxepin Hcl	30	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Prednisone	Prednisone	25	15
Risperidone	Risperidone	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	13
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Breyna	Budesonide/Formoterol Fumarate	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	11
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Colchicine	Colchicine	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Nystatin	Nystatin	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Potassium Citrate Er	Potassium Citrate	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lactulose	Lactulose	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Clonidine	Clonidine	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Etodolac	Etodolac	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sumatriptan	Sumatriptan	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error